Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Link opens in a new tab
Search content at UTMB Health Research Expert Profiles
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
tPA regulates pulmonary vascular activity through NMDA receptors
Taher Nassar
, Khalil Bdeir
, Serge Yarovoi
, Rami Abu Fanne
, Juan Carlos Murciano
, Steven Idell
, Timothy Craig Allen
, Douglas B. Cines
, Abd Al Roof Higazi
Research output
:
Contribution to journal
›
Article
›
peer-review
17
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'tPA regulates pulmonary vascular activity through NMDA receptors'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
N-methyl-D-aspartate Receptor (NMDAR)
100%
Vascular Function
100%
Pulmonary Vascular
100%
Plasminogen Activator
100%
Pulmonary Embolism
37%
Docking Site
37%
Pulmonary Artery
25%
Pulmonary Arterial
25%
Contractility
25%
Receptor Subtypes
25%
Catalytic Activity
25%
Murine Model
12%
Plasminogen Activator inhibitor-1 (PAI-1)
12%
Tissue Plasminogen Activator (t-PA)
12%
Fibrinolysis
12%
Vascular Permeability
12%
Dose Effect
12%
Risk-benefit
12%
Vascular Contraction
12%
Thrombotic
12%
High Concentration
12%
Phenylephrine
12%
Vascular Occlusion
12%
Arterial Ring
12%
Arterial Contraction
12%
Pulmonary Vascular Permeability
12%
Thrombolytic Agents
12%
Acute Coronary Event
12%
Hexapeptide
12%
Coronary Artery Obstruction
12%
Fibrinolytic Enzyme
12%
Medicine and Dentistry
NMDA Receptor
100%
Plasminogen Activator
100%
Muscle Contractility
37%
Pulmonary Embolism
37%
Receptor
25%
Blood Vessel Permeability
25%
Pulmonary Artery
25%
Dextro Aspartic Acid
25%
Tissue Plasminogen Activator
12%
Phenylephrine
12%
Vascular Occlusion
12%
Fibrinolysis
12%
Thrombolytic Drug
12%
Disease
12%
Coronary Artery Obstruction
12%
Hexapeptide
12%
Fibrinolysin
12%
Plasminogen Activator Inhibitor-1
12%
Pharmacology, Toxicology and Pharmaceutical Science
N Methyl Dextro Aspartic Acid Receptor
100%
Plasminogen Activator
100%
Lung Embolism
37%
Receptor
25%
Dextro Aspartic Acid
25%
Plasmin
12%
Fibrinolytic Agent
12%
Plasminogen Activator Inhibitor 1
12%
Tissue Plasminogen Activator
12%
Phenylephrine
12%
Blood Vessel Occlusion
12%
Coronary Artery Obstruction
12%
Hexapeptide
12%